Production method for recombinant human granulocyte colony-stimulating factor
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- BEIJING FOUR RINGS BIOPHARM
- Publication Date
- 2014-03-05
Abstract
Description
technical field
[0001] The invention relates to the field of biopharmaceuticals, in particular to a production method of recombinant human granulocyte stimulating factor. Background technique
[0002] Recombinant human granulocyte-stimulating factor (granulocyte colony-stimulating factor, G-CSF) refers to specifically acting on neutrophil progenitor cells in the hematopoietic system, promoting their proliferation, differentiation into mature neutrophils, and maintaining the survival of cells and their biological A hematopoietic growth factor that functions as a colony-stimulating factor that stimulates bone marrow cell colony formation. It has obvious curative effect on neutrophil increase during bone marrow transplantation, severe neutropenia caused by cancer chemotherapy, and neutropenia accompanied by aplastic anemia.
[0003] The biological activity of recombinant G-CSF by genetic engineering technology is similar to that of natural one, and it can be produced in large ...